PLK4 as a Novel Therapeutic Target in TP53-mutant Acute Myeloid Leukemia

Authors

Sima Fay Koyfman, Bryn Mawr CollegeFollow
Jingqi Pei PhD, The University of Texas MD Anderson Cancer Center
Po Yee Mak MS, The University of Texas MD Anderson Cancer Center
Edward Ayoub PhD, The University of Texas MD Anderson Cancer Center
Michael Andreeff MD, PhD, The University of Texas MD Anderson Cancer Center
Bing Z. Carter PhD, The University of Texas MD Anderson Cancer Center

Files

Program Affiliation

University Outreach - Bryn Mawr College

Keywords

AML, TP53, PLK4, Polyploidy, Apoptosis

Recommended Citation

Koyfman, Sima Fay; Pei, Jingqi PhD; Mak, Po Yee MS; Ayoub, Edward PhD; Andreeff, Michael MD, PhD; and Carter, Bing Z. PhD, "PLK4 as a Novel Therapeutic Target in TP53-mutant Acute Myeloid Leukemia" (2023). 2023 Summer Experience. 54.
https://openworks.mdanderson.org/sumexp23/54